AIM
Price:
$0.2569
Market Cap:
$16.27M
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of nat...[Read more]
Industry
Biotechnology
IPO Date
1996-07-12
Stock Exchange
AMEX
Ticker
AIM
According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.07M. This represents a change of -5.93% compared to the average of 17.08M of the last 4 quarters.
The mean historical Enterprise Value of AIM ImmunoTech Inc. over the last ten years is 14.29M. The current 16.07M Enterprise Value has changed 11.15% with respect to the historical average. Over the past ten years (40 quarters), AIM's Enterprise Value was at its highest in in the June 2021 quarter at 61.86M. The Enterprise Value was at its lowest in in the December 2022 quarter at -11218510.88.
Average
14.29M
Median
13.11M
Minimum
-11230050.87
Maximum
44.94M
Discovering the peaks and valleys of AIM ImmunoTech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 201.56%
Maximum Annual Enterprise Value = 44.94M
Minimum Annual Increase = -246.29%
Minimum Annual Enterprise Value = -11230050.87
Year | Enterprise Value | Change |
---|---|---|
2023 | 16.43M | -246.29% |
2022 | -11230050.87 | -196.74% |
2021 | 11.61M | -44.14% |
2020 | 20.78M | 201.56% |
2019 | 6.89M | -49.25% |
2018 | 13.58M | 29.83% |
2017 | 10.46M | -17.29% |
2016 | 12.65M | -24.62% |
2015 | 16.78M | -62.66% |
2014 | 44.94M | 1.14% |
The current Enterprise Value of AIM ImmunoTech Inc. (AIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.60M
5-year avg
8.90M
10-year avg
14.29M
AIM ImmunoTech Inc.’s Enterprise Value is greater than Aptorum Group Limited (8.77M), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), greater than BioCardia, Inc. (8.05M), greater than Virax Biolabs Group Limited (5.49M), greater than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-8886223.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.42M), greater than Forte Biosciences, Inc. (-3195101.00), less than Cellectar Biosciences, Inc. (57.01M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), less than Tonix Pharmaceuticals Holding Corp. (24.56M), greater than Onconova Therapeutics, Inc. (4.51M), less than Jaguar Health, Inc. (27.72M), less than Vaxart, Inc. (144.74M), less than VBI Vaccines Inc. (39.99M), greater than Pulmatrix, Inc. (-6183620.00), less than Capricor Therapeutics, Inc. (839.91M), less than Akari Therapeutics, Plc (26.33M), less than Soleno Therapeutics, Inc. (2.13B),
Company | Enterprise Value | Market cap |
---|---|---|
8.77M | $7.41M | |
-5743713.00 | $11.01M | |
-6447751.00 | $4.42M | |
8.05M | $8.33M | |
5.49M | $8.86M | |
8.67M | $3.41M | |
-8886223.00 | $3.19M | |
1.48M | $4.17M | |
4.42M | $10.92M | |
-3195101.00 | $6.38M | |
57.01M | $82.35M | |
-1447403.00 | $8.98M | |
24.56M | $19.46M | |
4.51M | $20.90M | |
27.72M | $9.61M | |
144.74M | $164.89M | |
39.99M | $1.87M | |
-6183620.00 | $7.59M | |
839.91M | $845.38M | |
26.33M | $29.50M | |
2.13B | $2.18B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AIM ImmunoTech Inc.'s Enterprise Value?
What is the highest Enterprise Value for AIM ImmunoTech Inc. (AIM)?
What is the 3-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?
What is the 5-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?
How does the current Enterprise Value for AIM ImmunoTech Inc. (AIM) compare to its historical average?